5:07 PM
 | 
Aug 26, 2013
 |  BC Extra  |  Company News

FDA approves Ceptaris' Valchlor, Actelion deal marches on

Actelion Ltd. (SIX:ATLN) said it is proceeding with its acquisition of Ceptaris Therapeutics Inc. (Malvern, Pa.) after FDA approved an NDA from Ceptaris for Valchlor mechlorethamine...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >